Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
© 2022, Bi et al..
IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
eLife - 11(2022) vom: 03. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bi, Yanxia [VerfasserIn] |
---|
Links: |
---|
Themen: |
ADAMTS13 |
---|
Anmerkungen: |
Date Completed 19.08.2022 Date Revised 07.09.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.7554/eLife.76223 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344401987 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344401987 | ||
003 | DE-627 | ||
005 | 20231226022702.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7554/eLife.76223 |2 doi | |
028 | 5 | 2 | |a pubmed24n1147.xml |
035 | |a (DE-627)NLM344401987 | ||
035 | |a (NLM)35920621 | ||
035 | |a (PII)e76223 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bi, Yanxia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.08.2022 | ||
500 | |a Date Revised 07.09.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022, Bi et al. | ||
520 | |a IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a ADAMTS13 | |
650 | 4 | |a Fc-FcγR interaction | |
650 | 4 | |a IgG4 | |
650 | 4 | |a autoantibody | |
650 | 4 | |a desmoglein 1 | |
650 | 4 | |a human | |
650 | 4 | |a immunology | |
650 | 4 | |a inflammation | |
650 | 4 | |a mouse | |
650 | 7 | |a Autoantibodies |2 NLM | |
650 | 7 | |a Desmoglein 1 |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a Receptors, IgG |2 NLM | |
700 | 1 | |a Su, Jian |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Shengru |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Yingjie |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yan |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Huihui |e verfasserin |4 aut | |
700 | 1 | |a Liu, Mingdong |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Aiwu |e verfasserin |4 aut | |
700 | 1 | |a Xu, Jianrong |e verfasserin |4 aut | |
700 | 1 | |a Pan, Meng |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Yiming |e verfasserin |4 aut | |
700 | 1 | |a Li, Fubin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t eLife |d 2012 |g 11(2022) vom: 03. Aug. |w (DE-627)NLM221831460 |x 2050-084X |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g day:03 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.7554/eLife.76223 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |b 03 |c 08 |